Ammonium Chloride → HCID 59716617、化合物
反応式
[CH3:1][Mg+].[Br-].[Cl:4][C:5]1[CH:10]=[CH:9][C:8]([C:11]2[CH:16]=[N:15][N:14]3[C:17](=[O:27])[N:18]([CH2:20][C:21](=[O:26])[CH2:22][O:23][CH2:24][CH3:25])[N:19]=[C:13]3[C:12]=2[C:28]2[CH:33]=[CH:32][C:31]([Cl:34])=[CH:30][CH:29]=2)=[CH:7][CH:6]=1.[NH4+].[Cl-]>>[Cl:4][C:5]1[CH:6]=[CH:7][C:8]([C:11]2[CH:16]=[N:15][N:14]3[C:17](=[O:27])[N:18]([CH2:20][C:21]([OH:26])([CH3:1])[CH2:22][O:23][CH2:24][CH3:25])[N:19]=[C:13]3[C:12]=2[C:28]2[CH:29]=[CH:30][C:31]([Cl:34])=[CH:32][CH:33]=2)=[CH:9][CH:10]=1参加物
反応条件
- 温度
- -78 °C
実験手順
MeMgBr (0.03 mL, 0.08 mmol, 3.0 M in Et2O) was added to a solution of 7,8-bis(4-chlorophenyl)-2-(3-ethoxy-2-oxopropyl)-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one, prepared as described in Example 30, (23 mg, 0.05 mmol) at −78° C. The reaction was stirred for 30 min. at −78° C. After this time, saturated aqueous NH4Cl (2 mL) was added to the reaction and the resultant solution was warmed to RT. The layers were separated and the aqueous layer was extracted with EtOAC (3×10 mL). The combined organic layers were dried (MgSO4), filtered, and concentrated. The crude product was purified by reverse phase HPLC to give the title compound, 7,8-bis(4-chlorophenyl)-2-(3-ethoxy-2-hydroxy-2-methylpropyl)-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one (4 mg, 16% yield) as a yellow oil. MS [M+H]+: found 473; 1H NMR (CDCl3, 400 MHz) δ 8.13 (s, 1H), 7.29-7.18 (m, 6H), 7.06-7.02 (m, 2H), 4.25 (d, 1H), 3.98 (d, 1H), 3.43 (q, 2H), 3.35 (d, 1H), 3.25 (d, 1H), 1.18 (s, 3H), 1.07 (t, 3H).
後処理
- customprepared
- customas described in Example 30, (23 mg, 0.05 mmol) at −78° C
- customThe layers were separated
- extractionthe aqueous layer was extracted with EtOAC (3×10 mL)
- dry with materialThe combined organic layers were dried (MgSO4)
- filtrationfiltered
- concentrationconcentrated
- customThe crude product was purified by reverse phase HPLC
出典と根拠
- ORDレコード
- ord-5d6a36b0aee0460cb43fb34f44256eac
- 出典データセット
- uspto-grants-2008_05
- 特許番号
- US07378418B2
反応ノート
読み込み中…